Clinical Trial Update: A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing etoposide/cisplatin with irinotecan/cisplatin for extensive-disease small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Clinical Research Center for Solid Tumor, Korea | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED